XML 49 R35.htm IDEA: XBRL DOCUMENT v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Apr. 30, 2020
Concentration Risk [Line Items]            
CARES Act grant           $ 11,700
Rebate receivable $ 39,900   $ 39,900   $ 35,200  
Investments in equity-method investees 19,900   19,900   $ 17,000  
Proportionate share of earnings in equity-method investees $ 1,700 $ 1,000 $ 2,891 $ 1,574    
Capital distribution received from investment   $ 0   $ 500    
Revenue from Contract with Customer Benchmark | Company's Largest Payer            
Concentration Risk [Line Items]            
Concentration ​risk 16.00% 16.00% 16.00% 15.00%    
Contract term     2 years      
Revenue from Contract with Customer Benchmark | Governmental Programs            
Concentration Risk [Line Items]            
Concentration ​risk 12.00% 12.00% 12.00% 12.00%    
Accounts Receivable | Governmental Programs            
Concentration Risk [Line Items]            
Concentration ​risk 13.00%       15.00%  
Cost of Goods and Service, Product and Service Benchmark | Medical Supply Vendors            
Concentration Risk [Line Items]            
Concentration ​risk 64.00% 72.00% 65.00% 72.00%